Praxis Precision Medicines (PRAX) Change in Acquisitions & Divestments (2021 - 2026)

Praxis Precision Medicines' Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $142.6 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 116.04% year-over-year to $142.6 million; the TTM figure through Mar 2026 stood at $389.3 million (up 105.96% YoY), while the FY2025 annual figure was $312.7 million, up 154.19% from the prior year.
• Change in Acquisitions & Divestments was $142.6 million for Q1 2026 at Praxis Precision Medicines, up from $61.9 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $142.6 million in Q1 2026 to a low of $3.0 million in Q2 2024.
• Historically, Change in Acquisitions & Divestments has averaged $57.0 million across 5 years, with a median of $58.9 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments sank 85.71% in 2023, then soared 1876.57% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $22.6 million in 2022, then slumped by 77.87% to $5.0 million in 2023, then surged by 1070.0% to $58.5 million in 2024, then grew by 5.78% to $61.9 million in 2025, then soared by 130.38% to $142.6 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $142.6 million (Q1 2026), $61.9 million (Q4 2025), and $125.5 million (Q3 2025), per Business Quant data.